| 15th
CVG ANNUAL CONFERENCE AND EXHIBITIONS (2009)
“Expand
your Horizon in a Challenging Time”
October 5,
2009 (Toronto,
Ontario, Canada)
Double Tree International Plaza Hotel, 655 Dixon Road, Toronto
Tel: 416-244-1711, www.internationalplaza.com
Conference Program
|
 |
|
|
|
| Introduction and Start of
Program |
|
8:40AM - 8:45AM |
|
| Opening Remarks |
Herman
Lam, Ph.D.
|
8:45AM - 8:50PM |
|
Key Note Address:
Biomarkers
(Not Posted)
|
Michael Siu, Ph.D.
York University
|
8:50AM - 9:35AM |
|
|
GMP
on Natural Health Products |
Raymond
Tsang
Health Canada |
9:35AM - 10:20AM |
|
| Morning Break |
|
10:20AM - 10:50AM |
|
| USP
Compendial Updates |
Behnam
Davani, Ph.D., USP
|
10:50AM - 11:25AM |
|
|
High
Resolution and Ultrahigh Resolution Mass Spectrometry
|
Vince Taguchi, Ph.D. Ministry of Environment
|
11:25AM - 12:00PM |
|
| Lunch Break |
|
12:00PM - 2:00PM |
|
|
| |
October
5 2009: Parallel Discussion Sessions (2:PM to 5 PM)
|
|
|
Session
1: Analytical Sciences
Chair: Herman Lam,Ph.D.
|
|
| Survive and
Thrive during Challenging Times by Harnessing the Power of Sub-2um
Particles |
Christine
Hand, Ph.D.
Waters |
|
| Recent
advances in elemental analysis |
Jeff
Bown
ThermoScientific |
|
| Break |
|
|
|
Applications
of Dielectric Constant Spectroscopy to Pharmaceuticals
|
Hitoshi Masui, Ph.D.
Prollennium |
|
| Laser
diffraction - the particle sizing workhorse of the pharmaceutical
industry |
Alan
Rawle Ph.D. Malvern Instruments Inc.
|
|
| Accelerating
Biomarker Assay Development to Validation: Use of Real Time
Immunoassay (Not Posted) |
Paul
Smith
Axela |
|
Session 2: Pharmaceutical Sciences and Regulatory
Chair:
Elaine Vandenberg, Ph.D., GlaxoSmithKline Canada Inc.
|
|
|
Use
of material science in pharmaceutical development
(Not Posted)
|
Kwok
Chow, Ph.D.
Patheon |
|
| Application
of Raman Spectroscopy for Pharmaceutical Raw Material
Identification (Not Posted) |
Krystyna Poblocka,
Ph.D.
Novopharm |
|
| Break |
|
|
| Economic
downturn - how does it affect pharmaceutical industry and you? |
YC,. Lee, Ph.D.
XPhase Pharma |
|
| Certification
of pharmaceutics reference standards |
John
Tobin. Ph.D.
Acanthus Research |
|
| How
Identification of Impurity Can Help to Achieve Optimal Stability
of Drug Products (Not Posted) |
Milica
Jovanovic
MJ Pharma |
|
|
|
